NAFDAC Nigeria approves use of AstraZeneca COVID-19 vaccine

0
526
The Oxford-AstraZeneca vaccine only offers limited protection against the variant first discovered in South Africa, new data suggests. /AP
The Oxford-AstraZeneca vaccine only offers limited protection against the variant first discovered in South Africa, new data suggests. /AP

Nigeria’s National Agency for Food and Drug Administration and Control, NAFDAC, Thursday approved the use of Oxford/AstraZeneca COVID_19 vaccine for use in the country.

In a press conference, Thursday morning, Professor Mojisola Adeyeye,Director-General of NAFDAC said the agency received the dossier of the vaccine a week ago, and the NAFDAC safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.

Prof. Adeyeye said the vaccine can be stored at 2 to 8-degree centigrade. According to the DG, there are three additional vaccines undergoing evaluation, but the evaluation on Astrazeneca shows that the vaccine is effective against the UK variant of the virus which has been reported in Nigeria.

She further disclosed that the South African variant has not been reported in Nigeria and that the agency has over 30 herbal medicine undergoing review for listing.

Nigeria which has to date registered 149,000 Coronavirus cases and 1,787 deaths is expected to get the first batch of the COVID_19 vaccines by the end of February.

(With input from agencies)

Leave a Reply